Hedge Funds Aren’t Crazy About Meridian Bioscience, Inc. (VIVO) Anymore
Is Meridian Bioscience, Inc.
Posts Tagged ‘NASDAQ:VIVO’
Is VIVO A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
Hedge Funds Are Crazy About Meridian Bioscience, Inc. (VIVO)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Did Hedge Funds Make The Right Call On Meridian Bioscience, Inc. (VIVO) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been This Bullish On Meridian Bioscience, Inc. (VIVO)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is Meridian Bioscience, Inc. (VIVO) Going to Burn These Hedge Funds?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Here’s What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO)
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Here’s What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO)
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved, lost nearly 40% of its value at one point in 2018.
Ex-CEO of TD Ameritrade Sells Shares, Co-Founder of Chipmaker Offloads Shares, Plus Insider Buying at Other Companies
A longstanding rule of thumb says that corporate insiders buy shares of their own companies for one simple reason – they believe Mr.
Is Meridian Bioscience, Inc. (VIVO) A Good Stock To Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Why Traders Are Watching Manhattan Associates, Meridian Bioscience, Puma Biotechnology, Tesla and More
With earnings season in full swing, volatility in the indices has trended a bit higher compared to that of previous weeks.
Nabors Industries Ltd. (NBR) and Two Other Companies Highlight Slow-Escalating Insider Buying
The aggregate dollar value of insider buying in April was lower than the value recorded in any other month in the past year or so, mainly owing to the first-quarter earnings season...
Hedge Funds Aren’t Crazy About Meridian Bioscience, Inc. (VIVO) Anymore
We can judge whether Meridian Bioscience, Inc.
Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock?
In the 21st century investor’s toolkit, there are many methods shareholders can use to track publicly traded companies.
Hedge Funds Are Crazy About IDEXX Laboratories, Inc. (IDXX)
In the 21st century investor’s toolkit, there are dozens of indicators market participants can use to watch the equity markets.
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
Abaxis Inc (ABAX): Insiders Aren’t Crazy About It
In today’s marketplace, there are many metrics investors can use to watch stocks. Two of the most under-the-radar are hedge fund and insider trading activity.
Hedge Funds Aren’t Crazy About Quidel Corporation (QDEL) Anymore
In today’s marketplace, there are many indicators shareholders can use to watch the equity markets.
Is Life Technologies Corp. (LIFE) Overvalued?
On April 15, Thermo fisher announced its acquisition of Life Technologies Corp. (NASDAQ:LIFE) for $13.6 billion plus approximately $2.2 billion in net debt.
Is IDEXX Laboratories, Inc. (IDXX) Going to Burn These Hedge Funds?
IDEXX Laboratories, Inc. (NASDAQ:IDXX) was in 11 hedge funds' portfolio at the end of the first quarter of 2013.
AstraZeneca plc (ADR) (AZN), Select Medical Holdings Corporation (SEM), Meridian Bioscience, Inc. (VIVO): Three High Dividend Healthcare Stocks
The U.S. government has been consistently cutting rates for the last few years. The aim of this exercise is to jump start the sluggish U.S. economy.
Meridian Bioscience, Inc. (VIVO): Hedge Funds and Insiders Are Bullish, What Should You Do?
Is Meridian Bioscience, Inc. (NASDAQ:VIVO) worth your attention right now? The best stock pickers are betting on the stock.
This Metric Says You Are Smart to Buy Synta Pharmaceuticals Corp. (SNTA)
In the 21st century investor’s toolkit, there are plenty of metrics shareholders can use to monitor their holdings.
